FDA Approves New Pancreatic Cancer Drug | Charlottesville News

FDA just approved Rasonque, a groundbreaking new drug targeting pancreatic cancer — a disease long considered nearly impossible to treat. This milestone offers renewed hope for patients and families facing one of medicine’s toughest battles, while also signaling that the fight against this deadly cancer is entering a new, more promising phase. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/64cafdcd840ce630